Physician profile
Thomas D Lee
NPI 1730441924
$1,512.62
in general payments reported to CMS, 2019-2025
8 companies · $169 in 2025
The $169 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $279 · 2022: $147 · 2023: $425 · 2024: $493 · 2025: $169.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $986 · Education: $99.88.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $986.37 |
| Education | $99.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $639.47 | 2021-2025 | Trigen Intertan, Journey II, Trigen Meta-Nail |
| 4web, INC. | $312.38 | 2024 | Spine Truss System |
| Depuy Synthes Sales INC. | $196.07 | 2021-2023 | Attune |
| Zimmer Biomet Holdings, INC. | $99.88 | 2023 | Avenir |
| Ortho Development Corporation | $84.89 | 2022 | |
| Stryker Corporation | $78.00 | 2023 | T2, Gamma |
| Kowa Pharmaceuticals America, INC. | $62.50 | 2022 | |
| Legacy Ortho LLC | $39.43 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.